Patent

5 stories about Patent
פרופסור זליג אשחר

Immunologists Exchange Verbal Blows in Legal Fight Over Kite Pharma Windfall

26.12.17|Zohar Shahar Levy
In August, Gilead Science bought anti-cancer treatment company Kite Pharma for $11.9 billion. Two Israeli scientists involved in the early research that led to the company’s breakthrough are now quarreling over patent royalty payments
מפעל חברת טבע הר חוצבים ירושלים

Teva's Blockbuster Drug Takes Another Generic Blow

26.10.17|Lilach Baumer
Mylan and European Partner Synthon won U.K. patent case related to Teva's Copaxone
בוריס בריאן רץ 800 לפני אתיופים ריו דה ז'נרו

Startup Contests Are Not for Everyone

22.10.17|Zachi Zach
If not carefully selected, a startup contest could hold more risk than value
חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
default image

Your First Investor Meeting, a Survival Guide

27.09.17|Zachi Zach
Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework